Synthesis of Nʹ-Nicotinoyl Sulfonohydrazides and their Antimicrobial Activity

2020 ◽  
Vol 42 (4) ◽  
pp. 597-597
Author(s):  
Zarina Arshad Zarina Arshad ◽  
Sumayya Saied Sumayya Saied ◽  
Basharat Ali Basharat Ali ◽  
Uzma Salar Uzma Salar ◽  
Saima Tauseef Saima Tauseef ◽  
...  

Nʹ-Nicotinoyl sulfonohydrazide derivatives 3-13 were synthesized from nicotinyl hydrazide and evaluated for their antimicrobial potential against Gram positive bacterial strains (Bacillus cereus, Bacillus subtilis, Corynebacterium diphtheriae, Staphylococcus fecalis, Staphylococcus aureus, and MRSA (Methicillin-resistant Staphylococcus aureus)) and Gram negative bacterial strains (Escherichia.coli, Pseudomonas aeruginosa, Salmonella ParatyphiB, Salmonella tyhpi). Compound 13 showed outstanding antibacterial activity against Staphylococcus fecalis and compounds 7 and 13 were found to be moderately activite against Salmonella Paratyphi B, shown by their zone of inhibition values. In addition to that compond 9 also showed moderate activity against Escherichia coli. All derivatives 3-13 were also subjected for the evaluation of their antifungal activity against Saccharomyces cerevisiae, Microsporum canin, Rhizopus, Aspergillus niger, Candida albicans, and Candida tropicalis. Compound 13 showed promising antifungal activity against Rhizopus sp. and compounds 9 and 10 showed moderate antifungal potential against Microsporum canis, Aspergillus niger, and Candida tropicalis. Other molecules demonstrated weak zone of inhibitions.

Author(s):  
Haribhai Rabari ◽  
Hetal Vankar ◽  
Beenkumar Prajapati

The emergence of multidrug microbial resistance is the main challenges that the modern scientists have so far been facing in the recent era. In this respect, new series of drug classes having potential to give antimicrobial effect have been synthesized. A new series of 5- substituted-1,10 b-dihydroimidazole[1,2-c]quinazoline derivatives 8a-e have been synthesized and screened for antibacterial activity and antifungal activity. Synthesized derivatives were characterized by IR, MASS and 1H-NMR spectroscopy. Synthesized compounds show good activity, which was comparable to the standard drug and it can be useful for the further clinical study. Antibacterial activity was evaluated against four different pathogenic bacterial strains like Staphylococcus aureus, Enterococcus faecalis, Escherichia coli and Pseudo-monas aeruginosa. Among the screened compounds, 8e show good antibacterial activity against Staphylococcus aureus and Escherichia coli with MIC of 50 and 100 μg/ml respectively. Antifungal activity was evaluated  against two strains of fungi. Among the synthesized derivates, compound 8c was emerged out as the potent antifungal compound against Candida albicans and Aspergillus niger with MIC of 25 μg/ml and 75μg/ml respectively. Compound 8e also shows good antifungal activity with MIC of 50 μg/ml against both Candida albicans and Aspergillus niger. The overall results of this study indicated that  synthesized quinazoline derivatives had the potential to act as an antibacterial and antifungal agent, hence further investigation is warranted.


2020 ◽  
Vol 15 (6) ◽  
pp. 665-679
Author(s):  
Alok K. Srivastava ◽  
Lokesh K. Pandey

Background: [1, 3, 4]oxadiazolenone core containing chalcones and nucleosides were synthesized by Claisen-Schmidt condensation of a variety of benzaldehyde derivatives, obtained from oxidation of substituted 5-(3/6 substituted-4-Methylphenyl)-1, 3, 4-oxadiazole-2(3H)-one and various substituted acetophenone. The resultant chalcones were coupled with penta-O-acetylglucopyranose followed by deacetylation to get [1, 3, 4] oxadiazolenone core containing chalcones and nucleosides. Various analytical techniques viz IR, NMR, LC-MS and elemental analysis were used to confirm the structure of the synthesised compounds.The compounds were targeted against Bacillus subtilis, Staphylococcus aureus and Escherichia coli for antibacterial activity and Aspergillus flavus, Aspergillus niger and Fusarium oxysporum for antifungal activity. Methods: A mixture of Acid hydrazides (3.0 mmol) and N, Nʹ- carbonyl diimidazole (3.3 mmol) in 15 mL of dioxane was refluxed to afford substituted [1, 3, 4]-oxadiazole-2(3H)-one. The resulted [1, 3, 4]- oxadiazole-2(3H)-one (1.42 mmol) was oxidized with Chromyl chloride (1.5 mL) in 20 mL of carbon tetra chloride and condensed with acetophenones (1.42 mmol) to get chalcones 4. The equimolar ratio of obtained chalcones 4 and β -D-1,2,3,4,6- penta-O-acetylglucopyranose in presence of iodine was refluxed to get nucleosides 5. The [1, 3, 4] oxadiazolenone core containing chalcones 4 and nucleosides 5 were tested to determined minimum inhibitory concentration (MIC) value with the experimental procedure of Benson using disc-diffusion method. All compounds were tested at concentration of 5 mg/mL, 2.5 mg/mL, 1.25 mg/mL, 0.62 mg/mL, 0.31 mg/mL and 0.15 mg/mL for antifungal activity against three strains of pathogenic fungi Aspergillus flavus (A. flavus), Aspergillus niger (A. niger) and Fusarium oxysporum (F. oxysporum) and for antibacterial activity against Gram-negative bacterium: Escherichia coli (E. coli), and two Gram-positive bacteria: Staphylococcus aureus (S. aureus) and Bacillus subtilis(B. subtilis). Result: The chalcones 4 and nucleosides 5 were screened for antibacterial activity against E. coli, S. aureus and B. subtilis whereas antifungal activity against A. flavus, A. niger and F. oxysporum. Compounds 4a-t showed good antibacterial activity whereas compounds 5a-t containing glucose moiety showed better activity against fungi. The glucose moiety of compounds 5 helps to enter into the cell wall of fungi and control the cell growth. Conclusion: Chalcones 4 and nucleosides 5 incorporating [1, 3, 4] oxadiazolenone core were synthesized and characterized by various spectral techniques and elemental analysis. These compounds were evaluated for their antifungal activity against three fungi; viz. A. flavus, A. niger and F. oxysporum. In addition to this, synthesized compounds were evaluated for their antibacterial activity against gram negative bacteria E. Coli and gram positive bacteria S. aureus, B. subtilis. Compounds 4a-t showed good antibacterial activity whereas 5a-t showed better activity against fungi.


Biomolecules ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 745
Author(s):  
Melaine González-García ◽  
Fidel Morales-Vicente ◽  
Erbio Díaz Pico ◽  
Hilda Garay ◽  
Daniel G. Rivera ◽  
...  

Cm-p5 is a snail-derived antimicrobial peptide, which demonstrated antifungal activity against the pathogenic strains of Candida albicans. Previously we synthetized a cyclic monomer as well as a parallel and an antiparallel dimer of Cm-p5 with improved antifungal activity. Considering the alarming increase of microbial resistance to conventional antibiotics, here we evaluated the antimicrobial activity of these derivatives against multiresistant and problematic bacteria and against important viral agents. The three peptides showed a moderate activity against Pseudomonas aeruginosa, Klebsiella pneumoniae Extended Spectrum β-Lactamase (ESBL), and Streptococcus agalactiae, with MIC values > 100 µg/mL. They exerted a considerable activity with MIC values between 25–50 µg/mL against Acinetobacter baumanii and Enterococcus faecium. In addition, the two dimers showed a moderate activity against Pseudomonas aeruginosa PA14. The three Cm-p5 derivatives inhibited a virulent extracellular strain of Mycobacterium tuberculosis, in a dose-dependent manner. Moreover, they inhibited Herpes Simplex Virus 2 (HSV-2) infection in a concentration-dependent manner, but had no effect on infection by the Zika Virus (ZIKV) or pseudoparticles of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2). At concentrations of >100 µg/mL, the three new Cm-p5 derivatives showed toxicity on different eukaryotic cells tested. Considering a certain cell toxicity but a potential interesting activity against the multiresistant strains of bacteria and HSV-2, our compounds require future structural optimization.


2002 ◽  
Vol 8 (5) ◽  
pp. 269-274 ◽  
Author(s):  
V. Zelenák ◽  
K. Györyová ◽  
D. Mlynarcík

The antibacterial and antifungal activity of zinc(II) carboxylates with composition Zn(RCOO)2•nH2O(R =H-, CH3− , CH3CH2CH2- , (CH3)2CH- , XCH2- , X=Cl, Br, I, n=0 or 2), [ZnX2(Nia+CH2COO-)2] (Nia=nicotinamide, X=Cl, Br, I) and [Zn(XCH2COO)2(Caf)2]•2H2O (Car=caffeine, X=Cl, Br) is studied against bacterial strains Staphylococcus aureus, Escherichia coli and yeast Candida albicans. The structural types are assigned to the prepared compounds and the influence of (i) carboxylate chain length, (ii) substitution of hydrogen atom of carboxylate by halogen and (iii) presence of N-donor organic ligands on the biological activity is discussed.


Author(s):  
M Shoeb ◽  
MIR Mamun ◽  
N Nahar ◽  
M Mosihuzzaman

Different extracts of the leaves and barks of Zizyphus rugosa and Zizyphus oenoplia were studied for their antibacterial, antifungal, and b-glucuronidase inhibitory activities. The methanol extract of Z. rugosa bark showed significant antibacterial activity against Streptococcus pyogens, Staphylococcus aureus and Pseudomonas aerogenes whereas the methanol extract of leaves demonstrated moderate activity against Salmonella typhi. The chloroform and methanol extracts of Z. oenoplia showed good activity against a few bacteria strains. The chloroform extracts of the barks and leaves of Z. rugosaalso showed antifungal activity. The methanol and ethyl acetate extracts of the bark of Z. rugosa revealed significant b-glucuronidase inhibitory activity. Lupeol, betuline, betulinaldehyde and betulinic acid, isolated from Z. rugosa, also showed good activity against a few bacteria. Key words: Zizyphus rugosa, Zizyphus oenoplia, Antibacterial, Antifungal, b-glucuronidase inhibition Dhaka Univ. J. Pharm. Sci. Vol.4(2) 2005 The full text is of this article is available at the Dhaka Univ. J. Pharm. Sci. website


2008 ◽  
Vol 3 (1) ◽  
pp. 1934578X0800300
Author(s):  
M. Mukhlesur Rahman ◽  
Alexander I. Gray ◽  
Proma Khondkar ◽  
M. Anwarul Islam

Eight alkaloids (2–9) and two lignans (1 and 10) isolated from the stem bark of Zanthoxylum budrunga were tested against a panel of bacteria (both Gram positive and Gram negative) and fungi. Significant antibacterial activities were exhibited by all compounds against the test bacterial strains, except Klebsiella aerogenes. All compounds except the mixture of 2 and 3 showed reasonable antifungal activity against Aspergillus niger and Candida albicans. The MICs of the compounds against the test organisms were recorded in the range of 0.06–1.568 μmol.


2020 ◽  
Vol 2 (3) ◽  
pp. 47-50
Author(s):  
Raphael Mordi ◽  
Ayodele O Olomieja ◽  
Gbenga E. Jolayemi ◽  
Fisayo E Owolabi

A steam distillation technique was employed to obtain oil from the leaf of P. alliacea. The oil obtained was subjected to GC/MS analysis to determine the chemical components, which showed the presence of sulphur heterocyclic compounds, 1,2,3-trithiolane (3), 1,2,5 trithiepane (4) and 1,2,5,6-tetrathiocane (7) as well as benzenecarbothioic acid (8) that have not been reported previously as components in the crude extracts of Petiveria alliacea. The crude extracts showed antimicrobial activity on the following microorganisms Salmonella typhi, Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Rhizopus sp., Aspergillus niger. The tests showed that the extract was most effective at limiting the growth of Salmonella typhi and the Rhizopus sp. (MIC 3.125 µg/mL and MBC value of 6.25 µg/mL). The ethanol extract using the Soxhlet technique was the most effective on Staphylococcus aureus, Escherichia coli, Rhizopus sp., and Aspergillus niger (MIC 3.125 µg/mL).


2009 ◽  
Vol 12 (1) ◽  
pp. 41-47 ◽  
Author(s):  
Julio R. Ruiz Q. ◽  
Mirtha Roque A.

Se investigó la actividad antimicrobiana in vitro de los extractos metanólicos, etanólicos e hidroalcohólicos de cuatro plantas del nor-oriente peruano: Cassia reticulata (planta entera), Ilex guayusa Loes (hojas), Piper lineatum (hojas), y Terminalia catappa (hojas). Las especies fueron recolectadas en el departamento de Cajamarca, excepto Terminalia catappa (Amazonas). La actividad antimicrobiana se evaluó mediante el método de difusión en agar. Los microorganismos utilizados fueron las bacterias Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Bacillus subtilis y Escherichia coli; y los hongos Candida albicans, Aspergillus niger y Microsporum canis. De doce extractos investigados, ocho (67%) presentaron actividad antimicrobiana significativa frente a Staphylococcus aureus y Staphylococcus epidermidis y uno (8%) frente a Escherichia coli. De doce extractos investigados, diez (83%) presentaron actividad significativa frente a Candida albicans, y seis (50%) contra Microsporum canis. Los extractos con la mejor actividad actimicrobiana fueron los tres extractos del Piper lineatum; el extracto hidroalcohólico de Cassia reticulata y el hidroalcohólico de Terminalia catappa.


Author(s):  
V. K. Robinson ◽  
B. Samuel-Penu ◽  
S. O. Minimah

The susceptibility of fungal isolates associated with indoor air of medical institutions to commonly used antifungal agents were investigated using the open plate technique on Sabouraud Dextrose Agar plates. The well in agar diffusion technique was used in determining the antifungal susceptibility. The antifungal agents used were fluconazole and ketoconazole and these drugs were prepared into four concentrations. Result showed reduced antifungal activity as the concentration decreased. Results of fluconazole against the fungal isolates showed that Aspergillus flavus, Aspergillus niger, Candida sp, and Mucor sp were all sensitive at 5 mg/ml, 2.5 mg/ml, and 1.25 mg/ml while Rhizopus sp was only sensitive at the 5mg/ml concentration. Antifungal activity of ketoconazole showed that Aspergillus flavus, Candida sp, Mucor sp and Rhizopus sp were all sensitive at the 5, 2.5, 1.25 and 0.63 mg/ml concentrations while A. niger was susceptible to ketoconazole at 5 and 2.5 mg/ml concentrations. The MIC of Ketoconazole against Candida sp, Aspergillus flavus, Mucor sp and Rhizopus sp was 0.63 mg/ml. while the MIC of Aspergillus niger was at 2.5 mg/ml. There was highly significant difference (P≤0.05) in the response of the fungal isolates to fluconazole and ketoconazole in all concentrations of the drugs. Result also showed that both drugs were more effective against Candida sp and because of the effectiveness of ketoconazole on other isolates, it is recommended for use in treating mycoses caused by these fungi from this site.


2019 ◽  
Author(s):  
Anup Masih ◽  
Jitendra Kumar Shrivastava ◽  
Hans Raj Bhat ◽  
Udaya Pratap Singh

Abstract The compounds were tested against panel of three Gram-positive, viz. Staphylococcus aureus, Bacillus subtilis, Bacillus cereus and three Gram-negative bacterial strains viz. Pseudomonas aeruginosa, Escherichia coli, and Proteus vulgaris for determination of their antibacterial efficacy using cefixime as a standard drug. The antibiofilm activities of the compounds were determined against Staphylococcus aureus, and Bacillus subtilis. The most potent compounds 7l amd 7m found bacteriostatic in time kill assay via inhibition of DNA Gyrase enzyme. The metabolic liability of compound 7m was determined using RS-Predictor and MetaPrint 2D React. The antifungal activity against human fungal pathogens was also estimated, where these compounds showed considerable activity in comparison to standard. The in vivo antibacterial activity of compound 7m was also determined using S. aureus induced murine infection model.


Sign in / Sign up

Export Citation Format

Share Document